Inventor
Richard N. Kolesnick
Inventor
New York, NY, US
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C12NMicroorganisms or enzymes15%
A01KAnimal husbandry11%
C07KPeptides11%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
PatentTitleYear
10,975,169Methods for treating diabetic retinopathy using anti-ceramide monoclonal antibody 2A2202110,722,577Methods for treating GI syndrome and graft versus host disease202010,450,385Anti-ceramide antibodies201910,413,533Enhancement of tumor response to chemotherapy by activation of the ASMase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent201910,052,387Ceramide reversal of multi-drug resistance20189,592,238'Anti-ceramide monoclonal antibody 2A2'20178,562,993'Methods for treating GI syndrome and graft versus host disease'20138,283,459'Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis'20128,258,108'Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis'20127,850,984'Protection of the female reproductive system from natural and artificial insults'20107,528,116'Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis'20097,301,017'Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis'20077,195,775'Protection of the female reproductive system from natural and artificial insults'20076,790,627'Methods and compositions for the modulation of acid-sphingomyelinase-related apoptosis'20046,274,309'Method for the modulation of acid-sphingomyelinase-related apoptosis'20016,040,149'Assay for identifying agents which act on the ceramide-activated protein kinase, kinase suppressor of ras, and methods of using said agents'20005,451,518'Purified human ceramide-activated protein kinase'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–2013Patents assigned to SLOAN KETTERING INST CANCER (8)· patent assignee history
1995–2021Based in New York, NY, US· patent location history
2007–2017Patents assigned to KOLESNICK RICHARD N (4)· patent assignee history
2007–2012Patents assigned to XING HONGMEI R (3)· patent assignee history
2013–2017Patents assigned to ARAP WADIH (2)· patent assignee history
2018–2021Patents assigned to MEMORIAL SLOAN KETTERING CANCER CENTER (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SLOAN KETTERING INST CANCER | 8 | 1995–2013 |
| KOLESNICK RICHARD Nself | 4 | 2007–2017 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 4 | 2018–2021 |
| XING HONGMEI R | 3 | 2007–2012 |
| ARAP WADIH | 2 | 2013–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| New York, New York, US | 17 | 1995–2021 |